# Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis

> **NCT01617772** · PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 440 (estimated)

## Conditions studied

- Non-alcoholic Steatohepatitis

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** L-Carnitine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01617772
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2019-10
- **Final completion:** 2019-12
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01617772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01617772, "Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01617772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*